SeaStar Medical (ICU) Stock Price, News & Analysis

Company Overview

SeaStar Medical, Inc. (NASDAQ: ICU) is a medical device company focused on the development and commercialization of cerebral embolic protection systems for patients undergoing transcatheter aortic valve replacement (TAVR) procedures. The company’s mission is to reduce the risk of stroke and other neurologic events associated with structural heart interventions by capturing or deflecting embolic debris that can travel to the brain during catheter-based therapies.

The company’s flagship product, TriGUARD® 3, is a next-generation embolic deflection device designed to provide coverage of all three cerebral vessels during TAVR. TriGUARD 3 features an advanced frame and filter design that conforms to varying patient anatomies, enabling physicians to position the device safely and effectively without obstructing critical arterial access routes. SeaStar Medical continues to invest in clinical trials and registry studies to demonstrate the safety and performance of its technology and to support regulatory clearances in North America, Europe and other key markets.

Headquartered in Kansas City, Missouri, SeaStar Medical serves a global customer base through direct sales and distribution partnerships in Europe and parts of Asia Pacific, in addition to its U.S. operations. The company collaborates with interventional cardiologists, cardiac surgeons and research institutions to refine device design and expand indications. Its leadership team brings extensive experience from leading cardiovascular and medical device firms, guiding SeaStar Medical through product development, regulatory interactions and market introduction efforts to address the growing demand for neuroprotection in structural heart care.

Key Stats

• Today's Range: $0.56 to $0.67
• 50-Day Range: $0.55 to $1.24
• 52-Week Range: $0.31 to $4.28
• Volume: 2.00 million shs
• Average Volume: 3.11 million shs
• Market Capitalization: $17.81 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

SeaStar Medical Stock Analysis - MarketRank™

SeaStar Medical scored higher than 12% of companies evaluated by MarketBeat, and ranked 916th out of 942 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for SeaStar Medical.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of SeaStar Medical is -0.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of SeaStar Medical is -0.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

16.21% of the float of SeaStar Medical has been sold short.

Short Interest Ratio / Days to Cover

SeaStar Medical has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in SeaStar Medical has recently increased by 42.81%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

SeaStar Medical does not currently pay a dividend.

Dividend Growth

SeaStar Medical does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

16.21% of the float of SeaStar Medical has been sold short.

Short Interest Ratio / Days to Cover

SeaStar Medical has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in SeaStar Medical has recently increased by 42.81%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 3.9 / 5
• News Sentiment: 0.95

News Sentiment

SeaStar Medical has a news sentiment score of 0.95. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.72 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for SeaStar Medical this week, compared to 2 articles on an average week.

Search Interest

3 people have searched for ICU on MarketBeat in the last 30 days.

MarketBeat Follows

4 people have added SeaStar Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, SeaStar Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $38,850.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

Only 1.30% of the stock of SeaStar Medical is held by insiders.

Percentage Held by Institutions

Only 1.69% of the stock of SeaStar Medical is held by institutions.

ICU Stock Analysis - Frequently Asked Questions

How have ICU shares performed this year?

SeaStar Medical's stock was trading at $1.94 at the start of the year. Since then, ICU shares have decreased by 68.9% and is now trading at $0.6030.

How were SeaStar Medical's earnings last quarter?

SeaStar Medical Holding Corporation (NASDAQ:ICU) released its quarterly earnings results on Wednesday, August, 13th. The company reported ($0.18) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.43) by $0.25. The business had revenue of $0.34 million for the quarter, compared to the consensus estimate of $0.25 million.
Read the conference call transcript.

When did SeaStar Medical's stock split?

Shares of SeaStar Medical reverse split on the morning of Monday, June 10th 2024.The 1-25 reverse split was announced on Monday, June 10th 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, June 10th 2024. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Who are SeaStar Medical's major shareholders?

SeaStar Medical's top institutional shareholders include Trinity Financial Advisors LLC (0.18%). Insiders that own company stock include John Neuman, Kevin Chung, Heel Kenneth Van, Jennifer A Baird and Richard D Russell.
View institutional ownership trends.

How do I buy shares of SeaStar Medical?

Shares of ICU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of SeaStar Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that SeaStar Medical investors own include Meta Platforms (META), Pfizer (PFE), Energy Transfer (ET), JPMorgan Chase & Co. (JPM), Kinder Morgan (KMI) and Visa (V).

Company Calendar

• Last Earnings: 8/13/2025
• Today: 10/15/2025
• Next Earnings (Estimated): 11/12/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:ICU
• CIK: 1831868
• Web: seastarmedical.com
• Phone: 844-427-8100
• Fax: N/A
• Employees: 2
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($2.62)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$24.83 million
• Net Margins: -1,915.27%
• Pretax Margin: -1,914.88%
• Return on Equity: N/A
• Return on Assets: -232.65%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.52
• Quick Ratio: 1.50

Sales & Book Value

• Annual Sales: $766 thousand
• Price / Sales: 20.75
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.34) per share
• Price / Book: -1.67

Miscellaneous

• Outstanding Shares: 27,915,000
• Free Float: 27,552,000
• Market Cap: $15.89 million
• Optionable: Not Optionable
• Beta: -1.07